HDAC1 PREDICTOR: a simple and transparent application for virtual screening of histone deacetylase 1 inhibitors

References

• J. Ferlay, M. Ervik, F. Lam, M. Colombet, L. Mery, M. Piñeros, A. Znaor, I. Soerjomataram, and F. Bray, Global Cancer Observatory: Cancer Today, International Agency for Research on Cancer, Lyon, France, 2020.
   Google Scholar
• J.E. Bolden, M.J. Peart, and R.W. Johnstone, Anticancer activities of histone deacetylase inhibitors, Nat. Rev. Drug Discov. 5 (2006), pp. 769–784. doi:10.1038/nrd2133.
   PubMed Web of Science ®Google Scholar
• V.N. Osipov, D.S. Khachatryan, and A.N. Balaev, Biologically active quinazoline-based hydroxamic acids, Med. Chem. Res. 29 (2020), pp. 831–845. doi:10.1007/s00044-020-02530-7.
   Web of Science ®Google Scholar
• C.A. Dinarello, G. Fossati, and P. Mascagni, Histone deacetylase inhibitors for treating a spectrum of diseases not related to cancer, Mol. Med. 17 (2011), pp. 333–352. doi:10.2119/molmed.2011.00116.
   PubMed Web of Science ®Google Scholar
• M. Halili, M. Andrews, M. Sweet, and D. Fairlie, Histone deacetylase inhibitors in inflammatory disease, Curr. Top. Med. Chem. 9 (2009), pp. 309–319. doi:10.2174/156802609788085250.
   PubMed Web of Science ®Google Scholar
• Y.H. Kao, J.P. Liou, C.C. Chung, G.S. Lien, C.C. Kuo, S.A. Chen, and Y.J. Chen, Histone deacetylase inhibition improved cardiac functions with direct antifibrotic activity in heart failure, Int. J. Cardiol. 168 (2013), pp. 4178–4183. doi:10.1016/j.ijcard.2013.07.111.
   PubMed Web of Science ®Google Scholar
• E.N. Muratov, J. Bajorath, R.P. Sheridan, I.V. Tetko, D. Filimonov, V. Poroikov, T.I. Oprea, I.I. Baskin, A. Varnek, A. Roitberg, O. Isayev, S. Curtalolo, D. Fourches, Y. Cohen, A. Aspuru-Guzik, D.A. Winkler, D. Agrafiotis, A. Cherkasov, and A. Tropsha, QSAR without borders, Chem. Soc. Rev. 49 (2020), pp. 3525–3716.
   PubMed Web of Science ®Google Scholar
• H. Tang, X.S. Wang, X.P. Huang, B.L. Roth, K.V. Butler, A.P. Kozikowski, M. Jung, and A. Tropsha, Novel inhibitors of human histone deacetylase (HDAC) identified by QSAR modeling of known inhibitors, virtual screening, and experimental validation, J. Chem. Inf. Model. 49 (2009), pp. 461–476. doi:10.1021/ci800366f.
   PubMed Web of Science ®Google Scholar
• L. Zhao, Y. Xiang, J. Song, and Z. Zhang, A novel two-step QSAR modeling work flow to predict selectivity and activity of HDAC inhibitors, Bioorg. Med. Chem. Lett. 23 (2013), pp. 929–933. doi:10.1016/j.bmcl.2012.12.067.
   PubMed Web of Science ®Google Scholar
• S.K. Choubey and J. Jeyaraman, A mechanistic approach to explore novel HDAC1 inhibitor using pharmacophore modeling, 3D- QSAR analysis, molecular docking, density functional and molecular dynamics simulation study, J. Mol. Graph. Model. 70 (2016), pp. 54–69. doi:10.1016/j.jmgm.2016.09.008.
   PubMed Web of Science ®Google Scholar
• J. Shi, G. Zhao, and Y. Wei, Computational QSAR model combined molecular descriptors and fingerprints to predict HDAC1 inhibitors, Med. Sci. 34 (2018), pp. 52–58. doi:10.1051/medsci/201834f110.
   Google Scholar
• U. Norinder, J.J. Naveja, E. López-López, D. Mucs, and J.L. Medina-Franco, Conformal prediction of HDAC inhibitors, SAR QSAR Environ. Res. 30 (2019), pp. 265–277. doi:10.1080/1062936X.2019.1591503.
   PubMed Web of Science ®Google Scholar
• H. Pham-The, G. Casañola-Martin, K. Diéguez-Santana, N. Nguyen-Hai, N.T. Ngoc, L. Vu-Duc, and H. Le-Thi-Thu, Quantitative structure-activity relationship analysis and virtual screening studies for identifying HDAC2 inhibitors from known HDAC bioactive chemical libraries, SAR QSAR Environ. Res. 28 (2017), pp. 199–220. doi:10.1080/1062936X.2017.1294198.
   PubMed Web of Science ®Google Scholar
• D. Mendez, A. Gaulton, A.P. Bento, J. Chambers, M. De Veij, E. Félix, M.P. Magariños, J.F. Mosquera, P. Mutowo, M. Nowotka, M. Gordillo-Marañón, F. Hunter, L. Junco, G. Mugumbate, M. Rodriguez-Lopez, F. Atkinson, N. Bosc, C.J. Radoux, A. Segura-Cabrera, A. Hersey, and A.R. Leach, ChEMBL: Towards direct deposition of bioassay data, Nucl. Acids Res. 47 (2019), pp. D930–D940. doi:10.1093/nar/gky1075.
   PubMed Web of Science ®Google Scholar
• O.V. Tinkov, V.Y. Grigorev, L.D. Grigoreva, V.N. Osipov, A.V. Kolotaev, and D.S. Khachatryan, QSAR analysis and experimental evaluation of new quinazoline-containing hydroxamic acids as histone deacetylase 6 inhibitors, SAR QSAR Environ. Res. 33 (2022), pp. 513–532. doi:10.1080/1062936X.2022.2092210.
   PubMed Web of Science ®Google Scholar
• D.E. Olson, F.F. Wagner, T. Kaya, J.P. Gale, N. Aidoud, E.L. Davoine, F. Lazzaro, M. Weïwer, Y.L. Zhang, and E.B. Holson, Discovery of the first histone deacetylase 6/8 dual inhibitors, J. Med. Chem. 56 (2013), pp. 4816–4820. doi:10.1021/jm400390r.
   PubMed Web of Science ®Google Scholar
• S. Tan, F. He, T. Kong, J. Wu, and Z. Liu, Design, synthesis and tumor cell growth inhibitory activity of 3-nitro-2H-cheromene derivatives as histone deacetylaes inhibitors, Bioorg. Med. Chem. 25 (2017), pp. 4123–4132. doi:10.1016/j.bmc.2017.05.062.
   PubMed Web of Science ®Google Scholar
• Z. Yang, T. Wang, F. Wang, T. Niu, Z. Liu, X. Chen, C. Long, M. Tang, D. Cao, X. Wang, W. Xiang, Y. Yi, L. Ma, J. You, and L. Chen, Discovery of selective histone deacetylase 6 inhibitors using the quinazoline as the cap for the treatment of cancer, J. Med. Chem. 59 (2016), pp. 1455–1470. doi:10.1021/acs.jmedchem.5b01342.
   PubMed Web of Science ®Google Scholar
• Y. Chen, X. Wang, W. Xiang, L. He, M. Tang, F. Wang, T. Wang, Z. Yang, Y. Yi, H. Wang, T. Niu, L. Zheng, L. Lei, X. Li, H. Song, and L. Chen, Development of purine-based hydroxamic acid derivatives: Potent histone deacetylase inhibitors with marked in vitro and in vivo antitumor activities, J. Med. Chem. 59 (2016), pp. 5488–5504. doi:10.1021/acs.jmedchem.6b00579.
   PubMed Web of Science ®Google Scholar
• D.N. Reddy, F. Ballante, T. Chuang, A. Pirolli, B. Marrocco, and G.R. Marshall, Design and synthesis of simplified largazole analogues as isoform-selective human lysine deacetylase inhibitors, J. Med. Chem. 59 (2016), pp. 1613–1633. doi:10.1021/acs.jmedchem.5b01632.
   PubMed Web of Science ®Google Scholar
• X. Chen, S. Zhao, H. Li, X. Wang, A. Geng, H. Cui, T. Lu, Y. Chen, and Y. Zhu, Design, synthesis and biological evaluation of novel isoindolinone derivatives as potent histone deacetylase inhibitors, Eur. J. Med. Chem. 168 (2019), pp. 110–122. doi:10.1016/j.ejmech.2019.02.032.
   PubMed Web of Science ®Google Scholar
• Y. Chen, X. Yuan, W. Zhang, M. Tang, L. Zheng, F. Wang, W. Yan, S. Yang, Y. Wei, J. He, and L. Chen, Discovery of novel dual histone deacetylase and mammalian target of rapamycin target inhibitors as a promising strategy for cancer therapy, J. Med. Chem. 62 (2019), pp. 1577–1592. doi:10.1021/acs.jmedchem.8b01825.
   PubMedGoogle Scholar
• J. Cheng, J. Qin, S. Guo, H. Qiu, and Y. Zhong, Design, synthesis and evaluation of novel HDAC inhibitors as potential antitumor agents, Bioorg. Med. Chem. Lett. 24 (2014), pp. 4768–4772. doi:10.1016/j.bmcl.2014.06.080.
   PubMedGoogle Scholar
• M. Shao, L. He, L. Zheng, L. Huang, Y. Zhou, T. Wang, Y. Chen, M. Shen, F. Wang, Z. Yang, and L. Chen, Structure-based design, synthesis and in vitro antiproliferative effects studies of novel dual BRD4/HDAC inhibitors, Bioorg. Med. Chem. Lett. 27 (2017), pp. 4051–4055. doi:10.1016/j.bmcl.2017.07.054.
   PubMed Web of Science ®Google Scholar
• Y. Wan, Y. Li, C. Yan, M. Yan, and Z. Tang, Indole: A privileged scaffold for the design of anti-cancer agents, Eur. J. Med. Chem. 183 (2019), pp. 111691. doi:10.1016/j.ejmech.2019.111691.
   PubMed Web of Science ®Google Scholar
• R. Sangwan, R. Rajan, and P.K. Mandal, HDAC as onco target: Reviewing the synthetic approaches with SAR study of their inhibitors, Eur. J. Med. Chem. 158 (2018), pp. 620–706. doi:10.1016/j.ejmech.2018.08.073.
   PubMed Web of Science ®Google Scholar
• S.C. Ding, Y.Z. Chen, Y.Z. Chen, Y.Z. Chen, Y.Z. Chen, Y.Z. Chen, Y. Jiang, and Y. Jiang, Synthesis and investigation of novel 6-(1,2,3-triazol-4-yl)-4-aminoquinazolin derivatives possessing hydroxamic acid moiety for cancer therapy, Bioorg. Med. Chem. 25 (2017), pp. 27–37. doi:10.1016/j.bmc.2016.10.006.
   PubMed Web of Science ®Google Scholar
• G. Estiu, N. West, R. Mazitschek, E. Greenberg, J.E. Bradner, and O. Wiest, On the inhibition of histone deacetylase 8, Bioorg. Med. Chem. 18 (2010), pp. 4103–4110. doi:10.1016/j.bmc.2010.03.080.
   PubMed Web of Science ®Google Scholar
• H. Hu, F. Chen, Y. Dong, M. Li, S. Xu, M. Qin, and P. Gong, Discovery of novel c-mesenchymal-epithelia transition factor and histone deacetylase dual inhibitors, Eur. J. Med. Chem. 204 (2020), pp. 112651. doi:10.1016/j.ejmech.2020.112651.
   PubMed Web of Science ®Google Scholar
• K. Fang, G. Dong, Y. Li, S. He, Y. Wu, S. Wu, W. Wang, and C. Sheng, Discovery of novel indoleamine 2,3-dioxygenase 1 (IDO1) and histone deacetylase (HDAC) dual inhibitors, ACS Med. Chem. Lett. 9 (2018), pp. 312–317. doi:10.1021/acsmedchemlett.7b00487.
   PubMed Web of Science ®Google Scholar
• F. Yang, P. Shan, N. Zhao, D. Ge, K. Zhu, C.S. Jiang, P. Li, and H. Zhang, Development of hydroxamate-based histone deacetylase inhibitors containing 1,2,4-oxadiazole moiety core with antitumor activities, Bioorg. Med. Chem. Lett. 29 (2019), pp. 15–21. doi:10.1016/j.bmcl.2018.11.027.
   PubMed Web of Science ®Google Scholar
• Z. Yuan, S. Chen, Q. Sun, N. Wang, D. Li, S. Miao, C. Gao, Y. Chen, C. Tan, and Y. Jiang, Olaparib hydroxamic acid derivatives as dual PARP and HDAC inhibitors for cancer therapy, Bioorg. Med. Chem. 25 (2017), pp. 4100–4109. doi:10.1016/j.bmc.2017.05.058.
   PubMed Web of Science ®Google Scholar
• O. Rabal, J.A. Sánchez-Arias, M. Cuadrado-Tejedor, I. de Miguel, M. Pérez-González, C. García-Barroso, A. Ugarte, A. Estella-Hermoso de Mendoza, E. Sáez, M. Espelosin, S. Ursua, T. Haizhong, W. Wei, X. Musheng, A. Garcia-Osta, and J. Oyarzabal, Design, synthesis, biological evaluation and in vivo testing of dual phosphodiesterase 5 (PDE5) and histone deacetylase 6 (HDAC6)-selective inhibitors for the treatment of Alzheimer’s disease, Eur. J. Med. Chem. 150 (2018), pp. 506–524. doi:10.1016/j.ejmech.2018.03.005.
   PubMed Web of Science ®Google Scholar
• F.F. Wagner, D.E. Olson, J.P. Gale, T. Kaya, M. Weïwer, N. Aidoud, M. Thomas, E.L. Davoine, B.C. Lemercier, Y.L. Zhang, and E.B. Holson, Potent and selective inhibition of histone deacetylase 6 (HDAC6) does not require a surface-binding motif, J. Med. Chem. 56 (2013), pp. 1772–1776.
   PubMed Web of Science ®Google Scholar
• B. Ghosh, W.N. Zhao, S.A. Reis, D. Patnaik, D.M. Fass, L.H. Tsai, R. Mazitschek, and S.J. Haggarty, Dissecting structure-activity-relationships of crebinostat: Brain penetrant HDAC inhibitors for neuroepigenetic regulation, Bioorg. Med. Chem. Lett. 26 (2016), pp. 1265–1271. doi:10.1016/j.bmcl.2016.01.022.
   PubMed Web of Science ®Google Scholar
• J. Chen, D. Li, W. Li, J. Yin, Y. Zhang, Z. Yuan, C. Gao, F. Liu, and Y. Jiang, Design, synthesis and anticancer evaluation of acridine hydroxamic acid derivatives as dual Topo and HDAC inhibitors, Bioorg. Med. Chem. 26 (2018), pp. 3958–3966. doi:10.1016/j.bmc.2018.06.016.
   PubMed Web of Science ®Google Scholar
• J. Liu, J. Zhou, F. He, L. Gao, Y. Wen, L. Gao, P. Wang, D. Kang, and L. Hu, Design, synthesis and biological evaluation of novel indazole-based derivatives as potent HDAC inhibitors via fragment-based virtual screening, Eur. J. Med. Chem. 192 (2020), pp. 112189. doi:10.1016/j.ejmech.2020.112189.
   PubMed Web of Science ®Google Scholar
• Z. Yuan, Q. Sun, D. Li, S. Miao, S. Chen, L. Song, C. Gao, Y. Chen, C. Tan, and Y. Jiang, Design, synthesis and anticancer potential of NSC-319745 hydroxamic acid derivatives as DNMT and HDAC inhibitors, Eur. J. Med. Chem. 134 (2017), pp. 281–292. doi:10.1016/j.ejmech.2017.04.017.
   PubMed Web of Science ®Google Scholar
• T. Beckers, S. Mahboobi, A. Sellmer, M. Winkler, E. Eichhorn, H. Pongratz, T. Maier, T. Ciossek, T. Baer, G. Kelter, H. Fiebig, and M. Schmidt, Chimerically designed HDAC- and tyrosine kinase inhibitors. A series of erlotinib hybrids as dual-selective inhibitors of EGFR, HER2 and histone deacetylases, MedChemComm. 3 (2012), pp. 829–835. doi:10.1039/c2md00317a.
   Web of Science ®Google Scholar
• Y. Dong, H. Hu, Y. Sun, M. Qin, P. Gong, Y. Hou, and Y. Zhao, Design, synthesis and biological evaluation of novel c-Met/HDAC dual inhibitors, Bioorg. Med. Chem. Lett. 30 (2020), pp. 127610. doi:10.1016/j.bmcl.2020.127610.
   PubMed Web of Science ®Google Scholar
• M.J. Lai, H.L. Huang, S.L. Pan, Y.M. Liu, C.Y. Peng, H.Y. Lee, T.K. Yeh, P.H. Huang, C.M. Teng, C.S. Chen, H.Y. Chuang, and J.P. Liou, Synthesis and biological evaluation of 1-Arylsulfonyl-5-(N-hydroxyacrylamide)indoles as potent histone deacetylase inhibitors with antitumor activity in vivo, J. Med. Chem. 55 (2012), pp. 3777–3791. doi:10.1021/jm300197a.
   PubMed Web of Science ®Google Scholar
• M. Swain, MolVS: Molecule validation and standardization tool, 2019; software available at https://molvs.readthedocs.io/en/latest/guide/intro.html (Accessed September 20th 2022).
   Google Scholar
• G. Landrum, RDKit - open source toolkit for cheminformatics, 2013; software available at https://www.rdkit.org/docs/index.html (Accessed September 20th 2022).
   Google Scholar
• F. Pedregosa, G. Varoquaux, A. Gramfort, V. Michel, B. Thirion, O. Grisel, M. Blondel, P. Prettenhofer, R. Weiss, V. Dubourg, J. Vanderplas, A. Passos, D. Cournapeau, M. Brucher, M. Perrot, and E. Duchesnay, Scikit-learn: Machine learning in Python, Jmlr 12 (2011), pp. 2825–2830.
   Web of Science ®Google Scholar
• V.M. Alves, S.J. Capuzzi, R.C. Braga, D. Korn, J.E. Hochuli, K.H. Bowler, A. Yasgar, G. Rai, A. Simeonov, E.N. Muratov, A.V. Zakharov, and A. Tropsha, SCAM detective: Accurate predictor of small, colloidally aggregating molecules, J. Chem. Inf. Model. 60 (2020), pp. 4056–4063. doi:10.1021/acs.jcim.0c00415.
   PubMed Web of Science ®Google Scholar
• D. Krstajic, L.J. Buturovic, D.E. Leahy, and S. Thomas, Cross-validation pitfalls when selecting and assessing regression and classification models, J. Cheminform. 6 (2014), pp. 10. doi:10.1186/1758-2946-6-10.
   PubMed Web of Science ®Google Scholar
• IMSL, Fortran Numerical Libraries; 2021. software available at https://help.imsl.com/fortran/ (Accessed September 20th 2022).
   Google Scholar
• O.A. Raevsky, V. Yu, D.B.K. Grigor’ev, and N.S. Zefirov, Complete thermodynamic description of H-bonding in the framework of multiplicative approach, Quant. Struct. Act. Relat. 11 (1992), pp. 49–63. doi:10.1002/qsar.19920110109.
   Google Scholar
• V. Yu and L.D. Grigoreva, Calculation and properties of fractal descriptors for C2–C9 alkanes, Mosc. Univ. Chem. Bull. 71 (2016), pp. 199–204. doi:10.3103/S0027131416030056.
   Google Scholar
• Streamlit 1.10.0. An open-source Python library; software available at https://docs.streamlit.io/ (Accessed September 20th 2022).
   Google Scholar
• G. Van Rossum and F.L. Drake, Python 3 Reference Manual, CreateSpace, Scotts Valley, CA, 2009.
   Google Scholar
• C.R. Harris, K.J. Millman, S.J. van der Walt, R. Gommers, P. Virtanen, D. Cournapeau, E. Wieser, J. Taylor, S. Berg, N.J. Smith, R. Kern, M. Picus, S. Hoyer, M.H. van Kerkwijk, M. Brett, A. Haldane, J. Fernandez Del Rio, M. Wiebe, P. Peterson, P. Gerard-Marchant, K. Sheppard, T. Reddy, W. Weckesser, H. Abbasi, C. Gohlke, and T.E. Oliphant, Array programming with NumPy, Nature 585 (2020), pp. 357–362. doi:10.1038/s41586-020-2649-2.
   PubMed Web of Science ®Google Scholar
• W. McKinney, Data structures for statistical computing in Python, 9th Python in Science Conference, Austin, 2010.
   Google Scholar
• J.D. Hunter, Matplotlib: A 2D graphics environment, Comput. Sci. Eng. 9 (2007), pp. 90–95. doi:10.1109/MCSE.2007.55.
   Web of Science ®Google Scholar
• Click 8.1.3. Python composable command line interface toolkit; software available at https://github.com/pallets/click (Accessed September 20th 2022).
   Google Scholar
• Joblib: Running Python functions as pipeline jobs; software available at https://joblib.readthedocs.io/en/latest/ (Accessed September 20th 2022).
   Google Scholar
• py3Dmol is an object-oriented, webGL based JavaScript library for online molecular visualization; software available at https://github.com/3dmol/3Dmol.js/tree/master/py3Dmol (Accessed September 20th 2022).
   Google Scholar
• N. Rego and D. Koes, 3Dmol.js: Molecular visualization with WebGL, Bioinformatics. 31 (2015), pp. 1322–1324. doi:10.1093/bioinformatics/btu829.
   PubMed Web of Science ®Google Scholar
• S. Riniker and G.A. Landrum, Similarity maps - a visualization strategy for molecular fingerprints and machine-learning methods, J. Cheminform. 5 (2013), pp. article number: 43. doi:10.1186/1758-2946-5-43.
   Web of Science ®Google Scholar
• L.M. Butler, Y. Webb, D.B. Agus, B. Higgins, T.R. Tolentino, M.C. Kutko, M.P. LaQuaglia, M. Drobnjak, C. Cordon-Cardo, H.I. Scher, R. Breslow, V.M. Richon, R.A. Rifkind, and P.A. Marks, Inhibition of transformed cell growth and induction of cellular differentiation by pyroxamide, an inhibitor of histone deacetylase, Clin. Cancer Res. 7 (2001), pp. 962–970.
   PubMed Web of Science ®Google Scholar
• A.S. Madsen and C.A. Olsen, A potent trifluoromethyl ketone histone deacetylase inhibitor exhibits class-dependent mechanism of action, Med. Chem. Commun. 7 (2016), pp. 464–470. doi:10.1039/C5MD00451A.
   Google Scholar
• M. Dokmanovic, C. Clarke, and P.A. Marks, Histone deacetylase inhibitors: Overview and perspectives, Mol. Cancer Res. 5 (2007), pp. 981–989. doi:10.1158/1541-7786.MCR-07-0324.
   PubMed Web of Science ®Google Scholar
• A. Frühauf and F.-J. Meyer-Almes, Non-hydroxamatezinc-binding groups as warheads for histone deacetylases, Molecules 26 (2021), pp. 5151. doi:10.3390/molecules26175151.
   PubMed Web of Science ®Google Scholar
• A.S. Madsen, H.M.E. Kristensen, G. Lanz, and C.A. Olsen, The effect of various zinc binding groups on inhibition of histone deacetylases 1-11, ChemMedChem 9 (2014), pp. 614–626. doi:10.1002/cmdc.201300433.
   PubMed Web of Science ®Google Scholar
• T. Genkov and I. Ivanova, Effect of cytokinin-active phenylurea derivatives on shoot multiplication, Bulg. J. Plant Physiol. 21 (1995), pp. 73–83.
   Google Scholar
• E.W. Debler, G.F. Kaufmann, M.M. Meijler, A. Heine, J.M. Mee, G. Pljevaljcic, A.J. Di Bilio, P.G. Schultz, D.P. Millar, K.D. Janda, I.A. Wilson, H.B. Gray, and R.A. Lerner, Deeply inverted electron-hole recombination in a luminescent antibody-stilbene complex, Science 319 (2008), pp. 1232–1235. doi:10.1126/science.1153445.
   PubMed Web of Science ®Google Scholar
• F.W. Peng, T.T. Wu, Z.W. Ren, J.Y. Xue, and L. Shi, Hybrids from 4-anilinoquinazoline and hydroxamic acid as dual inhibitors of vascular endothelial growth factor receptor-2 and histone deacetylase, Bioorg. Med. Chem. Lett. 25 (2015), pp. 5137–5141. doi:10.1016/j.bmcl.2015.10.006.
   PubMed Web of Science ®Google Scholar
• F.W. Peng, J. Xuan, T.T. Wu, J.Y. Xue, Z.W. Ren, D.K. Liu, X.Q. Wang, X.H. Chen, J.W. Zhang, Y.G. Xu, and L. Shi, Design, synthesis and biological evaluation of N–phenylquinazolin–4–amine hybrids as dual inhibitors of VEGFR–2 and HDAC, Eur. J. Med. Chem. 109 (2016), pp. 1–12. doi:10.1016/j.ejmech.2015.12.033.
   PubMed Web of Science ®Google Scholar
• S. Kim, J. Chen, T. Cheng, A. Gindulyte, J. He, S. He, Q. Li, B.A. Shoemaker, P.A. Thiessen, B. Yu, L. Zaslavsky, J. Zhang, and E.E. Bolton, PubChem in 2021: New data content and improved web interfaces, Nucl. Acids Res. 49 (2019), pp. D1388–D1395. doi:10.1093/nar/gkaa971.
   Web of Science ®Google Scholar
• A. Daina, O. Michielin, and V. Zoete, SwissTargetPrediction: Updated data and new features for efficient prediction of protein targets of small molecules, Nucl. Acids Res. 47 (2019), pp. W357–W364. doi:10.1093/nar/gkz382.
   PubMed Web of Science ®Google Scholar